Barclays Maintains Overweight on American Tower, Lowers Price Target to $224
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Brendan Lynch has maintained an Overweight rating on American Tower (NYSE:AMT) but reduced the price target from $229 to $224.
January 24, 2024 | 8:39 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays has maintained an Overweight rating on American Tower but lowered the price target from $229 to $224, indicating a positive outlook with a slightly reduced growth expectation.
The maintenance of an Overweight rating suggests that Barclays continues to see American Tower as a good investment, but the reduction in the price target could reflect a minor adjustment in growth expectations or market conditions. This news is likely to be viewed neutrally by investors as it confirms a positive outlook, albeit with a slight decrease in the expected price level. The impact on the stock price in the short term is likely to be minimal as the adjustment is not significant.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100